STAFF PROFILE
Associate Professor Ravi Shukla
Position:
Associate Professor
College / Portfolio:
STEM College
School / Department:
STEM|School of Science
Phone:
+61399252970
Email:
ravi.shukla@rmit.edu.au
Campus:
City Campus
Contact me about:
Research supervision,
Media comments
Research overview
- Study of material cell interaction particularly nanomaterial endocytosis, toxicity and biocompatibility evaluations, bio-distribution and Immunogenicity of synthesized nanomaterials
- Synthesis and targeted delivery of multifunctional nanomaterials
- Safe nanomaterials for Biomedical applications following Chemical and Green
- Chemistry approach
- Tailored synthesis of hybrid nanostructured surfaces and colloids for applications in:
- Biological imaging (CT, MRI and Photo acoustic imaging)
- Cancer Nano-Brachytherapy
- Targeted drug delivery
- Antimicrobial applications of nanomaterials
- Nanomaterials and SERS based bio sensing of disease biomarker
Awards / Research highlights
- Nominated as University Early Career Research representative to participate Australian Academy of Science’s national meeting Science Pathways: Getting Science on the National Agenda at the Shine Dome in Canberra on 24-25 September 2012.
- Recipient of prestigious Vice Chancellor’s Research Fellowship for Health and Innovation Research in Cancer, RMIT University, Australia (Aug. 2011-July 2014)
- Recipient of prestigious Department of Biotechnology travel grant award for YIM-2011 Bhubaneswar meeting, India. Feb 12-17, 2011
- NCI Best Poster Presentation award at National Cancer Institute (NCI) Alliance for Nanotechnology in Cancer Investigators meeting. Los Angeles, USA. October 19-22, 2009
- Presentation on Avastin conjugated gold nanoparticles for ophthalmic drug delivery at ARVO 2009 conference in Florida on May 4th has been selected as Emerging Trends and Hot Topics in Ophthalmology see page 108 program# 2426.
- The impact of research work in ophthalmic drug delivery has been well recognized in the PXE patient community and the highlights of the work appeared in PXE news letter.
- Paper on Soybean mediated gold nanoparticle synthesis has been cited in High Tech Material Alerts (Oct 21, 2008) by Frost & Sullivan as well as by the Editor’s Choice Column of the prestigious journal Science in Oct. 10, 2008 issue.
- Best Abstract award at International Conference on Bioscience, Biotechnology & Biodiversity. Modern College, Pune, India [Oct 2005]
Patents
Katti KV, Kannan R, Katti K, Shukla R, Chanda N. Soy or lentil stabilized gold nanoparticles and method for making same. (Contribution 20%) Assigned No: 2009. 0117045
Hainsworth DP, Shukla R, Kannan R, Katti KV. Synthesis of Avastin conjugated gold nanoparticles. (Contribution 25%) (Provisional Patent assigned Serial No. PCT/US2011/056825)
A complete list of Dr Shukla's publications can be found at Google Scholar.
- Ph.D., Cell Biology (Biotechnology), National Centre for Cell Science & National Chemical Laboratory (NCL), Pune, India, (2007)
- M.Sc. Biomedical Biotechnology, Central JALMA Institute for Leprosy & School of Basic Science,
- Dr. B. R. Ambedkar University, Agra, India (1999)
- Post Graduate Diploma in Tissue Culture, Government Polytechnic Faizabad, India (1997)
- B.Sc., Chemistry & Zoology,Kanpur University India, (1996)
Professional affiliations and experience
- Aug 2011–Present: Vice Chancellor’s Research Fellow, School of Applied Sciences & Health Innovation Research Institute, RMIT University, Australia.
- March 2012– Present: Founder Member, Centre for Advanced Materials and Industrial Chemistry, RMIT University, Australia
- Aug 2007– Aug 2011: National Cancer Institute (Nanotechnology Platform) Post Doctoral Research Fellow, University of Missouri-Columbia, USA
- Aug 2007– Aug 2011: Joint Post Doctoral Fellow, Department of Ophthalmology, University of Missouri-Columbia, USA
- Jan 2008– Aug 2011: Research Consultant, Nanoparticle Biochem Inc., USA
- Aug 2002–July 2007: Department of Biotechnology (DBT), Government of India Senior Research Fellow (National Centre for Cell Science, India)
- 2006: Visiting Faculty, Poona College of Pharmacy, Bhartiya Vidyapeeth University, Pune, India
- Aug 2000– Aug 2002: Department of Biotechnology (DBT), Government of India Junior Research Fellow (National Centre for Cell Science, India)
- 2000: Lecturer, Department of Microbiology, DVS-CAST, D.A.V. College, Kanpur. India
Member of professional societies
- Australian Nanotechnology Network (ANN), Australia
- American Chemical Society (ACS), USA
- Association for Research in Vision and Ophthalmology, (ARVO) USA
- Institute of Nanotechnology (IoN) UK (Associate member)
- National Association of Pseudoxanthoma Elasticum (NAPE), USA
Editorial responsibilities
- Editorial Board Member: International Journal of Green Nanotechnology (Taylor and Francis) [2009 onwards]
- Editorial Associate: Synthesis & Reactivity in Inorganic, Metal-Organic and Nano-Metal Chemistry (Taylor and Francis) [2010 onwards)
- Reviewer: Nanomedicine (Elsevier) [2010 onwards],
- Reviewer: PLoS One [2011 onwards],
- Singh, M.,Thrimawithana, T.,Shukla, R.,Adhikari, B. (2022). Inhibition of enzymes associated with obesity by the polyphenol-rich extracts of Hibiscus sabdariffa In: Food Bioscience, 50, 1 - 1
- Bergamasco, E.,Peron, G.,Venerando, A.,Polash, S.,Shukla, R.,Sut, S.,Dall'Acqua, S.,Masi, A. (2022). Investigation of sulfur-containing compounds in spears of green and white Asparagus officinalis through LC-MS and HS-GC–MS In: Food Research International, 162 , 1 - 8
- Poddar, A.,Pyreddy, S.,Polash, S.,Doherty, C.,Shukla, R. (2022). A quest for cytocompatible metal organic frameworks in non-viral gene therapy: relevance of zeolitic imidazolate framework-8 In: Biomaterials and Biosystems, 8, 1 - 9
- Tagore, R.,Alagarasu, K.,Patil, P.,Pyreddy, S.,Polash, S.,Kakade, M.,Shukla, R.,Parashar, D. (2022). Targeted in vitro gene silencing of E2 and nsP1 genes of chikungunya virus by biocompatible zeolitic imidazolate framework In: Frontiers in Bioengineering and Biotechnology, 10, 1 - 13
- Singh, M.,Thrimawithana, T.,Shukla, R.,Brennan, C.,Adhikari, B. (2022). Impact of phenolic extracts and potassium hydroxycitrate of Hibiscus sabdariffa on adipogenesis: a cellular study In: International Journal of Food Science and Technology, 58, 1204 - 1218
- Singh, M.,Thrimawithana, T.,Shukla, R.,Adhikari, B. (2021). Extraction and characterization of polyphenolic compounds and potassium hydroxycitrate from Hibiscus sabdariffa In: Future Foods, 4, 1 - 10
- Polash, S.,Khare, T.,Kumar, V.,Shukla, R. (2021). Prospects of Exploring the Metal–Organic Framework for Combating Antimicrobial Resistance In: ACS Applied Bio Materials, 4, 8060 - 8079
- Reineck, P.,Abraham, A.,Poddar, A.,Shukla, R.,Abe, H.,Ohshima, T.,Gibson, B.,Dekiwadia, C.,Conesa, J.,Pereiro, E.,Gelmi, A.,Bryant, G. (2020). Multimodal Imaging and Soft X-Ray Tomography of Fluorescent Nanodiamonds in Cancer Cells In: Biotechnology Journal, , 1 - 8
- Poddar, A.,Pyreddy, S.,Carraro, F.,Dhakal, S.,Rassell, A.,Field, M.,Telukutla, S.,Falcaro, P.,Doherty, C.,Shukla, R. (2020). ZIF-C for targeted RNA interference and CRISPR/Cas9 based gene editing in prostate cancer In: Chemical Communications, 56, 15406 - 15409
- Francis, J.,Skakic, I.,Dekiwadia, C.,Shukla, R.,Taki, A.,Walduck, A.,Smooker, P. (2020). Solid lipid nanoparticle carrier platform containing synthetic TLR4 agonist mediates non-viral DNA vaccine delivery In: Vaccines, 8, 1 - 16
- DREAM-Nano Study: Developing a Robust and Efficient Analytical Method for diabetes progression using Nanotechnology (Administered by Western Sydney Uni). Funded by: The Leona M. and Harry B. Helmsley Charitable Trust - Grant from (2017 to 2023)
- Reviving Indian Rivers: Is nano-remediation the answer?. Funded by: Australia India Council Grant 2015 from (2016 to 2016)
- Radio-Magnetic Nanoparticles as Bimodal PET/MR Imaging Contrast Agents for Dendritic Cell Tracking. Funded by: ARC Linkage Grant 2013 from (2013 to 2018)
Note: Supervision projects since 2004
15 PhD Completions and 1 Masters by Research Completions6 PhD Current Supervisions
Molecular & Cell biology; Material-cellular interactions; Cancer nanotechnology; Nano-enabled proteomics and molecular target Identification; Advanced nanomaterials & biomaterials for imaging, drug delivery and theranostics.